BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29544685)

  • 1. Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity.
    Zomer-van Ommen DD; de Poel E; Kruisselbrink E; Oppelaar H; Vonk AM; Janssens HM; van der Ent CK; Hagemeijer MC; Beekman JM
    J Cyst Fibros; 2018 May; 17(3):316-324. PubMed ID: 29544685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis.
    Ramalho AS; Fürstová E; Vonk AM; Ferrante M; Verfaillie C; Dupont L; Boon M; Proesmans M; Beekman JM; Sarouk I; Vazquez Cordero C; Vermeulen F; De Boeck K;
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32747394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients.
    Boj SF; Vonk AM; Statia M; Su J; Vries RR; Beekman JM; Clevers H
    J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis.
    Vijftigschild LA; Berkers G; Dekkers JF; Zomer-van Ommen DD; Matthes E; Kruisselbrink E; Vonk A; Hensen CE; Heida-Michel S; Geerdink M; Janssens HM; van de Graaf EA; Bronsveld I; de Winter-de Groot KM; Majoor CJ; Heijerman HG; de Jonge HR; Hanrahan JW; van der Ent CK; Beekman JM
    Eur Respir J; 2016 Sep; 48(3):768-79. PubMed ID: 27471203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function.
    Clancy JP; Szczesniak RD; Ashlock MA; Ernst SE; Fan L; Hornick DB; Karp PH; Khan U; Lymp J; Ostmann AJ; Rezayat A; Starner TD; Sugandha SP; Sun H; Quinney N; Donaldson SH; Rowe SM; Gabriel SE
    PLoS One; 2013; 8(9):e73905. PubMed ID: 24040112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional CFTR assay using primary cystic fibrosis intestinal organoids.
    Dekkers JF; Wiegerinck CL; de Jonge HR; Bronsveld I; Janssens HM; de Winter-de Groot KM; Brandsma AM; de Jong NW; Bijvelds MJ; Scholte BJ; Nieuwenhuis EE; van den Brink S; Clevers H; van der Ent CK; Middendorp S; Beekman JM
    Nat Med; 2013 Jul; 19(7):939-45. PubMed ID: 23727931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.
    Dekkers JF; Berkers G; Kruisselbrink E; Vonk A; de Jonge HR; Janssens HM; Bronsveld I; van de Graaf EA; Nieuwenhuis EE; Houwen RH; Vleggaar FP; Escher JC; de Rijke YB; Majoor CJ; Heijerman HG; de Winter-de Groot KM; Clevers H; van der Ent CK; Beekman JM
    Sci Transl Med; 2016 Jun; 8(344):344ra84. PubMed ID: 27334259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R560S: A class II CFTR mutation that is not rescued by current modulators.
    Awatade NT; Ramalho S; Silva IAL; Felício V; Botelho HM; de Poel E; Vonk A; Beekman JM; Farinha CM; Amaral MD
    J Cyst Fibros; 2019 Mar; 18(2):182-189. PubMed ID: 30030066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations.
    Dekkers JF; Van Mourik P; Vonk AM; Kruisselbrink E; Berkers G; de Winter-de Groot KM; Janssens HM; Bronsveld I; van der Ent CK; de Jonge HR; Beekman JM
    J Cyst Fibros; 2016 Sep; 15(5):568-78. PubMed ID: 27160424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations.
    de Winter-de Groot KM; Berkers G; Marck-van der Wilt REP; van der Meer R; Vonk A; Dekkers JF; Geerdink M; Michel S; Kruisselbrink E; Vries R; Clevers H; Vleggaar FP; Elias SG; Heijerman HGM; van der Ent CK; Beekman JM
    J Cyst Fibros; 2020 Jul; 19(4):614-619. PubMed ID: 31735562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis.
    Liu Z; Anderson JD; Deng L; Mackay S; Bailey J; Kersh L; Rowe SM; Guimbellot JS
    Genes (Basel); 2020 May; 11(6):. PubMed ID: 32485957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function.
    de Winter-de Groot KM; Janssens HM; van Uum RT; Dekkers JF; Berkers G; Vonk A; Kruisselbrink E; Oppelaar H; Vries R; Clevers H; Houwen RHJ; Escher JC; Elias SG; de Jonge HR; de Rijke YB; Tiddens HAWM; van der Ent CK; Beekman JM
    Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30166324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia.
    Amatngalim GD; Rodenburg LW; Aalbers BL; Raeven HH; Aarts EM; Sarhane D; Spelier S; Lefferts JW; Silva IA; Nijenhuis W; Vrendenbarg S; Kruisselbrink E; Brunsveld JE; van Drunen CM; Michel S; de Winter-de Groot KM; Heijerman HG; Kapitein LC; Amaral MD; van der Ent CK; Beekman JM
    Life Sci Alliance; 2022 Aug; 5(12):. PubMed ID: 35922154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Functional Characteristics of the E92K
    Kondratyeva E; Melyanovskaya Y; Bulatenko N; Davydenko K; Filatova A; Efremova A; Skoblov M; Bukharova T; Sherman V; Voronkova A; Zhekaite E; Krasovskiy S; Amelina E; Petrova N; Polyakov A; Adyan T; Starinova M; Krasnova M; Vasilyev A; Makhnach O; Zinchenko R; Kutsev S; Gokdemir Y; Karadag B; Goldshtein D
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OrgaSegment: deep-learning based organoid segmentation to quantify CFTR dependent fluid secretion.
    Lefferts JW; Kroes S; Smith MB; Niemöller PJ; Nieuwenhuijze NDA; Sonneveld van Kooten HN; van der Ent CK; Beekman JM; van Beuningen SFB
    Commun Biol; 2024 Mar; 7(1):319. PubMed ID: 38480810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect.
    Wong SL; Awatade NT; Astore MA; Allan KM; Carnell MJ; Slapetova I; Chen PC; Setiadi J; Pandzic E; Fawcett LK; Widger JR; Whan RM; Griffith R; Ooi CY; Kuyucak S; Jaffe A; Waters SA
    Am J Respir Cell Mol Biol; 2022 Jul; 67(1):99-111. PubMed ID: 35471184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An organoid model to assay the role of CFTR in the human epididymis epithelium.
    Leir SH; Yin S; Kerschner JL; Xia S; Ahmadi S; Bear C; Harris A
    Cell Tissue Res; 2020 Aug; 381(2):327-336. PubMed ID: 32377875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo CF diagnosis by intestinal current measurements (ICM) in small aperture, circulating Ussing chambers.
    De Jonge HR; Ballmann M; Veeze H; Bronsveld I; Stanke F; Tümmler B; Sinaasappel M
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():159-63. PubMed ID: 15463951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data.
    Derichs N; Sanz J; Von Kanel T; Stolpe C; Zapf A; Tümmler B; Gallati S; Ballmann M
    Thorax; 2010 Jul; 65(7):594-9. PubMed ID: 20627915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of renewable mouse intestinal epithelial cell monolayers and organoids for functional analyses.
    Moorefield EC; Blue RE; Quinney NL; Gentzsch M; Ding S
    BMC Cell Biol; 2018 Aug; 19(1):15. PubMed ID: 30111276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.